Antibody persistence after primary vaccination with a hexavalent DTPa-HBV-IPV/HIB vaccine coadministered with a meningococcal C-CRM197 vaccine and response to a DTPa-IPV/HIB booster at 18 months of age

Pediatric Infectious Disease Journal

Volumn 25, Issue 10, 2006, Pages 943-945

  Tejedor, Juan Carlos ^a   Omeñaca, Félix ^b   García Sicilia, José ^b   Esporrín, Carlos ^c   Molina, Vicente ^d   Marés, Josep ^e   Muro, Marta ^f   Sanjuan, Pilar ^g   Méndez, María ^h   Teixidor, Roser ⁱ   Enrubia, Manuel ^j   García Corbeira, Pilar ^k,l   Boceta, Reyes ^k,l   Jacquet, Jeanne Marie ^k,l   Schuerman, Lode ^k,l  

^a HOSPITAL DE MÓSTOLES   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL SANTA CATERINA   (Spain)

^d INSTITUT UNIVERSITARI DEXEUS   (Spain)

^e Mares Riera Paediatric Institute   (Spain)

^f HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^g ABS Serraparera   (Spain)

^h ABS Mongat Tiana   (Spain)

ⁱ Hospital Sant Jaume de Olot   (Spain)

^j ABS Anoia Rural   (Spain)

^k GLAXOSMITHKLINE   (Spain)

^l GSK   (Belgium)

more..

Author keywords

Diphtheria tetanus toxoids acellular pertussis inactivated poliovirus Haemophilus influenzae vaccine; Diphtheria tetanus toxoids acellular pertussishepatitis B vaccine inactivated poliovirus Haemophilus influenzae b vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCUS VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; DIPHTHERIA; DRUG SAFETY; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS; PRIORITY JOURNAL; SKIN SWELLING; TETANUS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; MENINGOCOCCAL VACCINES; POLIOVIRUS VACCINE, INACTIVATED; VACCINATION; VACCINES, COMBINED;

EID: 33749451776     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000237917.60734.05     Document Type: Article

References (10)

1. Recommended childhood and adolescent immunization schedule: United States, January-June 2004. MMWR. 2004;16:53:Q1-Q4.
2. Tejedor JC, Omeñaca F, García-Sicilia G, et al. Immunogenicity and reactogenicity of a 3-dose combined primary vaccination course with a combined diphtheria-tetanus-3 component acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine co-administered with a meningococcal C conjugate vaccine. Pediatr Infect Dis J. 2004;23:1109-1115.
3. Saenger R, Maechler G, Potreck M, et al. Booster vaccination with hexavalent DTPa-HBV-IPV/Hib vaccine in the second year of life is as safe as concomitant DTPa-IPV/Hib + HBV administered separately. Vaccine. 2005;23:1135-1143.
4. Nolan T, Altmann A, Skeljo M, Streeton C, Schuerman L. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine. Vaccine. 2004;23:14-20.
5. Tichmann-Schumann I, Soemantri P, Behre U, et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2005;24:70-77.
6. 197 in United States infants. Pediatric Infect Dis J. 2001;20:153-159.
7. Richmond P, Borrow R, Miller E, et al. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis. 1999;179:1569-1572.
8. Snape MD, Pollard AJ. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis. 2005;5:21-30.
9. Rennels MB. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Pediatr Infect Dis. 2003;14:196-198.
10. Rennels MB, Deloria MA, Pichichero ME, et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics. 2000;105:e12.